Bausch Health Companies Inc | VRX - Cost Of Sales

Valeant Pharmaceuticals reported $652M in Cost of Sales for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cost Of Sales Change
Amgen AMGN:US USD 1.75B 159M
Ani Pharmaceuticals ANIP:US USD 36.33M 3.43M
Aurora Cannabis Inc ACB:CN CAD 84.15M 12.06M
Biogen BIIB:US USD 570.9M 101.4M
Bristol Myers Squibb BMY:US USD 2.52B 167M
Canopy Growth Corp WEED:CN CAD 103.65M 10.39M
Catalent CTLT:US USD 762M 2M
Corcept Therapeutics CORT:US USD 1.48M 141K
Danaher DHR:US USD 3.43B 351M
Drreddys Laboratories RDY:US INR 27.61B 1.8B
Eli Lilly And LLY:US USD 1.55B 31M
Endo International Ordinary Shares ENDP:US USD 176.86M 1.06M
Gilead Sciences GILD:US USD 1.4B 1000K
Horizon Pharma HZNP:US USD 240.79M 6.65M
JAZZ PHA JAZZ:US USD 167.36M 33.7M
Lannett LCI:US USD 66.62M 4.14M
Nektar Therapeutics NKTR:US USD 6.23M 1.26M
Pacira Pharmaceuticals PCRX:US USD 61.92M 11.24M
Perrigo Ordinary Shares PRGO:US USD 772.7M 35.4M
Phibro Animal Health PAHC:US USD 167.26M 3.39M
Prestige Brands PBH:US USD 125.12M 3.14M
Revance Therapeutics RVNC:US USD 23.52M 12.78M
Supernus Pharmaceuticals SUPN:US USD 22.95M 2.92M
Valeant Pharmaceuticals VRX:CN USD 652M 68M
Vertex Pharmaceuticals VRTX:US USD 283.3M 6.1M
Zoetis ZTS:US USD 651M 45M